Trilineage response to recombinant human granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome.
Rey
C
C
Bader-Meunier
B
B
Tertian
G
G
Mielot
F
F
Tchernia
G
G
Yver
A
A
D000293:Adolescent; D016913:Blood Component Transfusion; D005500:Follow-Up Studies; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000097:blood* / Q000188:drug therapy* / Q000628:therapy; D009504:Neutrophils / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors
D006454:Hemoglobins; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor